Skip to main content
HR 2009 115th Congress House Health Drug safety, medical device, and laboratory regulation Health technology, devices, supplies Medical tests and diagnostic methods Radiation

Fostering Innovation in Medical Imaging Act of 2017

Introduced: April 6, 2017 See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 7, 2017
Referred to the Subcommittee on Health.
Apr 6, 2017
Referred to the House Committee on Energy and Commerce.
Apr 6, 2017
Introduced in House
 Plain-English summary Congressional Research Service

Fostering Innovation in Medical Imaging Act of 2017

This bill amends the Federal Food, Drug, and Cosmetic Act to allow the Food and Drug Administration (FDA) to approve a medical imaging device intended to be used with an approved contrast agent when—under specified conditions—the use differs from the approved use of the contrast agent. (Contrast agents are substances used to enhance the visibility of body structures in medical imaging.) The FDA center that reviews medical devices has primary jurisdiction over such reviews.

After authorization of a medical imaging device that makes new use of a contrast agent, the sponsor of the approved contrast agent may submit a supplemental application for the new use of the contrast agent.

What's happening now April 7, 2017

Referred to the Subcommittee on Health.

 Committees of jurisdiction 2
 Cosponsors 2
All 2 Democratic 2